Session Objectives: Educate the FDA staff on the complex issues of Gorlin syndrome (GS), both related to the basal cell carcinoma’s (BCCs) and the variety of physical manifestations and body systems affected.  Educate the FDA staff on the serious impacts of GS disease manifestations on patients, the effects on quality of life, the currently available […]